Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention

The HIV epidemic continues unabated, with no highly effective vaccine and no cure. Each new infection has significant economic, social and human costs and prevention efforts are now as great a priority as global antiretroviral therapy (ART) scale up. Reverse transcriptase inhibitors, the first licen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Ravindra K, Van de Vijver, David A M C, Manicklal, Sheetal, Wainberg, Mark A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733946/
https://www.ncbi.nlm.nih.gov/pubmed/23902855
http://dx.doi.org/10.1186/1742-4690-10-82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733946/
https://www.ncbi.nlm.nih.gov/pubmed/23902855
http://dx.doi.org/10.1186/1742-4690-10-82

Ejemplares similares